1-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole is patented as a reagent to synthesize quinoxaline derivatives or heterocyclylamine derivatives as PI3 kinase inhibitors.
参考文献
Li, Y., et al.: PCT Int. Appl. (2013), WO 2013033569 A1 20130307; Chaudhari, A., et al.: PCT Int. Appl. (2008), WO 2008141065 A1 20081120.
沪ICP备17019645号
400-821-0725
